Highnoon Laboratories Limited (PSX:HINOON)
1,149.00
+9.02 (0.79%)
At close: Oct 21, 2025
Highnoon Laboratories Market Cap
Highnoon Laboratories has a market cap or net worth of 60.88 billion as of October 22, 2025. Its market cap has increased by 64.34% in one year.
Market Cap
60.88B
Enterprise Value
58.68B
Revenue
25.78B
Ranking
n/a
PE Ratio
17.31
Stock Price
1,149.00
Market Cap Chart
Since July 1, 1996, Highnoon Laboratories's market cap has increased from 188.06M to 60.88B, an increase of 32,272.33%. That is a compound annual growth rate of 21.79%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 21, 2025 | 60.88B | 25.13% |
Dec 31, 2024 | 48.65B | 81.98% |
Dec 29, 2023 | 26.73B | 18.17% |
Dec 30, 2022 | 22.62B | -5.37% |
Dec 31, 2021 | 23.91B | 15.14% |
Dec 31, 2020 | 20.76B | 22.81% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
GlaxoSmithKline Pakistan | 136.41B |
Abbott Laboratories (Pakistan) | 117.36B |
The Searle Company | 60.79B |
AGP Limited | 55.44B |
Shifa International Hospitals | 34.11B |
Citi Pharma | 20.45B |
Ferozsons Laboratories | 18.28B |
Macter International | 16.71B |